-
The FDA said Florida’s program will be authorized for two years. Approval comes after months of wrangling that led to the state filing two lawsuits against the agency.
-
The Georgia Board of Pharmacy began accepting applications to dispense the products in October. However, the DEA has reportedly warned pharmacies that dispensing medical marijuana violates federal law.
-
The White House unveiled a list of 48 drugs whose prices increased faster than the rate of inflation this year. Under a new law, drugmakers must pay rebates to the government because of it.
-
The Biden administration urged an appeals court to uphold a ruling that Florida violated federal law by blocking coverage for people seeking hormone therapy and puberty blockers.
-
Colorado officials say they haven’t been able to stand up a program to import drugs from Canada because of drugmaker opposition — and the Biden administration’s inaction.
-
The regulatory proposal was announced Nov. 15 and is likely one of the last major Obamacare policy efforts of the president’s term.
-
The hearing had been scheduled for Tuesday, but U.S. District Judge Marcia Morales Howard approved a continuance until Dec. 13 because the state’s lead lawyer was diagnosed this weekend with pneumonia.
-
Lina Khan, chair of the FTC, says a recent lawsuit is meant to chill the consolidation of medical groups that results in higher prices for consumers. But it may be too late to curb price hikes.
-
The president wants lawmakers to provide more funds to aid efforts to block fentanyl manufacturing and trafficking. He also says that a deal with China will require monitoring to have an impact.
-
A rule taking effect Jan. 1 was intended to stop one set of abuses by pharmacy benefit managers, but some pharmacists say it’s enabling these price brokers to simply do new things unfairly.